Abstrakt

Aim: The purpose of the study was to analyze the cognitive functions in postmenopausal women carriers of Apolipoprotein E gene polymorphisms (APOE) with different status of vitamin D levels. Material/Methods: 170 ambulatory individuals aged 50 years or older were evaluated. A computerized battery of Central Nervous System Vital Signs (CNS VS) was used for diagnostic cognitive functions. APOE genotype was performed by multiplex PCR. Serum 25(OH)D and estradiol levels were measured using the 25OHD EIA assay and Estradiol ELISA Kits. Results: Considerably worse scores in global cognitive performance index (NCI) were obtained by women with severe deficiency of 25(OH)D (p <0.001). The cognitive effects of very low 25(OH)D levels were apparent in memory, executive functioning, complex attention, and cognitive flexibility. The genotype APOE ε3/ε4 or ε4/ε4 were most common (19.6%; 15.2%, respectively) in women with 25(OH)D severe deficiency which had the weakest average results in terms of NCI value. Conclusions: The severe deficiency of 25(OH)D vitamin was related with a greater likelihood of cognitive impairment and risk of cognitive decline in postmenopausal women with no dementia.

Przypisy

• 1. Annweiler C., Montero-Odasso M., Llewellyn D.J., Richard-DevantoyS., Duque G., Beauchet O.: Meta-analysis of memory andexecutive dysfunction in relation to vitamin D. J. Alzheimers Dis.,2013; 37: 147–171
  Google Scholar
• 2. Annweiler C., Rolland Y., Schott A.M., Blain H., Vellas B., BeauchetO.: Serum vitamin D deficiency as a predictor of incident non-Alzheimerdementias: a 7-year longitudinal study. Dement. Geriatr. Cogn.Disord., 2011; 32: 273–278
  Google Scholar
• 3. Bagger Y.Z., Tankó L.B., Alexandersen P., Qin G., Christiansen C.,PERF Study Group: Early postmenopausal hormone therapy may preventcognitive impairment later in life. Menopause, 2005; 12: 12–17
  Google Scholar
• 4. Bojar I., Owoc J., Wójcik-Fatla A., Raszewski G., Stančiak J., RaczkiewiczD.: Cognitive functions, lipid profile, and Apolipoprotein Egene polymorphism in postmenopausal women. Ann. Agric. Environ.Med., 2015; 22: 313–319
  Google Scholar
• 5. Bojar I., Wojcik-Fatla A., Owoc A., Lewinski A.: Polymorphisms ofapolipoprotein E gene and cognitive functions of postmenopausalwomen, measured by battery of computer tests – central nervoussystem vital signs. Neuro. Endocrinol. Lett., 2012; 33: 385–392
  Google Scholar
• 6. Buell J.S., Scott T.M., Dawson-Hughes B., Dallal G.E., RosenbergI.H., Folstein M.F., Tucker K.L.: Vitamin D is associated with cognitivefunction in elders receiving home health services. J. Gerontol.A Biol. Sci. Med. Sci., 2009; 64: 888–895
  Google Scholar
• 7. Dean A.J., Bellgrove M.A., Hall T., Phan W.M., Eyles D.W., KvaskoffD., McGrath J.J.: Effects of vitamin D supplementation on cognitiveand emotional functioning in young adults: A randomized controltrial. PLoS One, 2011; 6: e25966
  Google Scholar
• 8. Etgen T., Sander D., Bickel H., Sander K., Förstl H.: Vitamin D deficiency,cognitive impairment and dementia: a systematic reviewand meta-analysis. Dement. Geriatr. Cogn. Disord., 2012; 33: 297–305
  Google Scholar
• 9. Geleijnse J.M.: Vitamin D and the prevention of hypertensionand cardiovascular diseases: a review of the current evidence. Am.J. Hypertens., 2011; 24: 253–262
  Google Scholar
• 10. Gualtieri C.T., Johnson L.G.: Reliability and validity of computerizedneurocognitive test battery, CNS Vital Signs. Arch. Clin. Neuropsychol.,2006; 21: 623–643
  Google Scholar
• 11. Holick M.F.: Vitamin D deficiency. N. Engl. J. Med., 2007; 357: 266–281
  Google Scholar
• 12. Huebbe P., Nebel A., Siegert S., Moehring J., Boesch-SaadatmandiC., Most E., Pallauf J., Egert S., Müller M.J., Schreiber S., Nöthlings U.,Rimbach G.: APOE ε4 is associated with higher vitamin D levels in targetedreplacement mice and humans. FASEB J., 2011; 25: 3262–3270
  Google Scholar
• 13. Llewellyn D.J., Lang I.A., Langa K.M., Muniz-Terrera G., PhillipsC.L., Cherubini A., Ferrucci L., Melzer D.: Vitamin D and risk of cognitivedecline in elderly persons. Arch. Intern. Med., 2010; 170: 1135–1141
  Google Scholar
• 14. Luine V.N.: Estradiol and cognitive function: past, present andfuture. Horm. Behav., 2014; 66: 602–618
  Google Scholar
• 15. Mcgreevy C., Williams D.: New insights about vitamin D and cardiovasculardisease: A narrative review. Ann. Intern. Med., 2011; 155: 820–826
  Google Scholar
• 16. Michos E.D., Carson K.A., Schneider A.L., Lutsey P.L., Xing L.,Sharrett A.R., Alonso A., Coker L.H., Gross M., Post W., Mosley T.H.,Gottesman RF.: Vitamin D and subclinical cerebrovascular disease:The atherosclerosis risk in communities brain magnetic resonanceimaging study. JAMA Neurol., 2014; 71: 863–871
  Google Scholar
• 17. Nilsson K., Gustafson L., Nornholm M., Hultberg B.: Plasma homocysteine,apolipoprotein E status and vascular disease in elderlypatients with mental illness. Clin. Chem. Lab. Med., 2010; 48: 129–135
  Google Scholar
• 18. Olsson E., Byberg L., Karlström B., Cederholm T., Melhus H.,Sjögren P., Kilander L.: Vitamin D is not associated with incidentdementia or cognitive impairment: an 18-y follow-up study in community-living old men. Am. J. Clin. Nutr., 2017; 105: 936–943
  Google Scholar
• 19. Overman M.J., Pendleton N., O’Neill T.W., Bartfai G., Casanueva F.F.,Finn J.D., Forti G., Rastrelli G., Giwercman A., Han T.S., Huhtaniemi I.T.,Kula K., Lean M.E.J., Punab M., Lee D.M., et al.: Evaluation of cognitivesubdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in theEuropean Male Ageing Study. Eur. J. Nutr., 2017; 56: 2093–2103
  Google Scholar
• 20. Pérez-López F.R.: Vitamin D metabolism and cardiovascularrisk factors in postmenopausal women. Maturitas, 2009; 62: 248–262
  Google Scholar
• 21. Pérez-López F.R., Brincat M., Erel C.T., Tremollieres F., GambaccianiM., Lambrinoudaki I., Moen M.H., Schenck-Gustafsson K., VujovicS., Rozenberg S., Rees M.: EMAS position statement: Vitamin Dand postmenopausal health. Maturitas, 2012; 71: 83–88
  Google Scholar
• 22. Raszewski G., Loroch M., Owoc A., Łukawski K., Filip R., Bojar I.:Homocysteine and cognitive disorders of postmenopausal womenmeasured by a battery of computer tests – central nervous systemvital signs. Arch. Womens Ment. Health, 2015; 18: 623–630
  Google Scholar
• 23. Schneider A.L., Zhao D., Lutsey P.L., Gottesman R.F., SharrettA.R., Rawlings A.M., Alonso A., Knopman D., Mosley T.H., Selvin E.,Michos E.D.: Serum vitamin D concentrations and cognitive changeover 20 years: The Atherosclerosis Risk in Communities NeurocognitiveStudy. Neuroepidemiology, 2018; 51: 131–137
  Google Scholar
• 24. Seamans K.M., Hill T.R., Scully L., Meunier N., Andrillo-SanchezM., Polito A., Hininger-Favier I., Ciarapica D., Simpson E.E., Stewart–Knox B.J., O’Connor J.M., Coudray C., Cashman K.D.: Vitamin D statusand measures of cognitive function in healthy older Europeanadults. Eur. J. Clin. Nutr., 2010; 64: 1172–1178
  Google Scholar
• 25. Slinin Y., Paudel M., Taylor B.C., Ishani A., Rossom R., Yaffe K.,Blackwell T., Lui L.Y., Hochberg M., Ensrud K.E., Study of OsteoporoticFractures Research Group: Association between serum 25(OH) vitaminD and the risk of cognitive decline in older women. J. Gerontol.A Biol. Sci. Med. Sci., 2012; 67: 1092–1098
  Google Scholar
• 26. Yang Y.G., Kim J.Y., Park S.J., Kim S.W., Jeon O.H., Kim D.S.: ApolipoproteinE genotyping by multiplex tetra-primer amplificationrefractory mutation system PCR in single reaction tube. J. Biotechnol.,2007; 131: 106–110
  Google Scholar
• 27. Zygouris S., Tsolaki M.: Computerized cognitive testing for olderadults: a review. Am. J. Alzheimers Dis. Other Demen., 2015; 30: 13–28
  Google Scholar

Pełna treść artykułu